VC
INAB icon

Voss Capital’s IN8bio INAB Stock Holding History

Voss Capital’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,133
Closed -$17.3K – 47
2024
Q3 		$17.3K Sell
2,133
-900
-30% -$16.3K ﹤0.01% 39
2024
Q2 		$77K Sell
3,033
-7,750
-72% -$249K 0.01% 38
2024
Q1 		$382K Sell
10,783
-591
-5% -$22.3K 0.03% 33
2023
Q4 		$471K Sell
11,374
-5,679
-33% -$182K 0.05% 40
2023
Q3 		$532K Buy
17,053
+1,790
+12% +$67.1K 0.07% 38
2023
Q2 		$705K Buy
15,263
+3,996
+35% +$250K 0.09% 43
2023
Q1 		$439K Hold
11,267
– – 0.06% 35
2022
Q4 		$781K Sell
11,267
-1,252
-10% -$70.1K 0.15% 38
2022
Q3 		$759K Sell
12,519
-4,336
-26% -$291K 0.22% 32
2022
Q2 		$1.14M Buy
16,855
+8,222
+95% +$695K 0.37% 28
2022
Q1 		$875K Buy
8,633
+5,240
+154% +$586K 0.28% 33
2021
Q4 		$446K Buy
3,393
+702
+26% +$139K 0.14% 36
2021
Q3 		$555K Buy
+2,691
New +$669K 0.23% 30

Other funds holding INAB

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Voss Capital's INAB Position: Q4 2024 in Review

Voss Capital sold out of IN8bio (INAB) in Q4 2024, closing a stake of 2,133 shares — an estimated $17.3K sold.

Voss Capital first reported a position in INAB in Q3 2021 and held it in 13 quarters. The position peaked at $1.14M in Q2 2022. 24 funds tracked by Wall St. Rank hold INAB as of Q4 2024.

  • Voss Capital reported no remaining IN8bio position as of Q4 2024 after selling out during the quarter.
  • Voss Capital sold 2,133 IN8bio shares in Q4 2024, an estimated $17.3K.
  • Voss Capital first reported a position in IN8bio in Q3 2021 and held it in 13 quarters.
  • Voss Capital's IN8bio position peaked at $1.14M in Q2 2022.
  • 24 funds tracked by Wall St. Rank held IN8bio as of Q4 2024.

Based on Voss Capital's 13F filing for Q4 2024, filed 13 Feb 2025.